{"filings":[{"id":99144,"accession_number":"0001213900-26-053854","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Vaso Corp. agrees to pay $175,000 incentive to subsidiary president for strategic goals","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Peter Castle, President of VasoTechnology, eligible for $175,000 incentive payment.","Payment contingent on achieving specified corporate objectives tied to potential strategic initiatives within a set time.","No payment if objectives not met or if Mr. Castle fails to comply with agreement terms.","Agreement entered May 4, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114996,"accession_number":"0001213900-26-015515","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Vaso Corporation amends Bylaws to add COO, remove written consent, allow virtual meetings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Removed stockholder right to act by written consent; now requires in-person or virtual meeting vote.","Added Chief Operating Officer role and separated duties of President and CEO.","Authorized virtual stockholder meetings and expanded board discretion on meeting timing.","Conformed quorum and director count to match Articles of Incorporation.","Updated indemnification provisions for officers, including mandatory expense advancement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131381,"accession_number":"0001213900-25-123593","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2025-12-19T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Vaso shareholders elect three directors, approve Say on Pay, choose triennial frequency","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected directors Behnam Movaseghi (103.7M for), Jane Moen (109.4M for), Leon Dembo (103.6M for) to three-year terms.","Non-binding Say on Pay proposal approved with 105.6M votes in favor, 12.8M against, 1.8M abstain.","Shareholders recommended triennial Say on Pay vote (97.7M for three years, 16.8M for one year); board adopted that frequency.","Next Say on Pay vote will be at the 2028 annual meeting; 120.2M of 175.9M outstanding shares voted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131380,"accession_number":"0001213900-25-112966","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Vaso sells VasoHealthcare IT to Nano-X for up to $800K; <5% of total revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale consideration up to $800K: $200K at closing, $600K earnout tied to post-close performance.","VasoHealthcare IT represented less than 5% of Vaso's total revenue; proceeds to fund other business lines.","Transaction expected to close within weeks; Vaso engaged Barley Snyder as legal counsel.","Divestiture follows strategic review; CEO cites sharper focus on core operations as reason."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184111,"accession_number":"0001213900-25-000753","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2025-01-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Vaso Corp appoints Jane Moen COO; Jonathan Newton named sole CFO and Secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jane Moen, age 45, appointed COO effective Jan 1, 2025; she remains President of Vaso Healthcare subsidiary.","Peter Castle steps down as COO but continues as President of VasoTechnology subsidiary.","Michael Beecher ends roles as Co-CFO and Secretary, remains as financial advisor.","Jonathan Newton becomes sole CFO, Treasurer, and Secretary, previously Co-CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216724,"accession_number":"0001213900-24-079992","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2024-09-19T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Vaso Corporation terminates business combination agreement with Achari Ventures Holdings Corp. I","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Vaso terminated the Business Combination Agreement with Achari on September 17, 2024.","The agreement dated December 6, 2023, would have made Vaso a wholly owned subsidiary of Achari.","Vaso issued a press release on September 18, 2024, announcing the termination.","Management plans to pursue internal growth, partnerships, and strategic investments in medical and IT services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216723,"accession_number":"0001213900-24-077416","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2024-09-10T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Vaso shareholders approve business combination with Achari; Nasdaq listing expected","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Special meeting held Sep 10, 2024; quorum of 129,015,962 shares (73.6% of voting power).","Shareholders approved business combination with 125,596,668 for, 3,345,378 against.","Directors Jun Ma (124,242,823 for) and David Lieberman (124,385,610 for) elected.","Ratification proposal approved with 125,487,261 for, 2,616,671 against.","Transaction expected to close promptly; post-closing common stock and warrants to trade on Nasdaq under VASO and VASOW."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216722,"accession_number":"0001213900-24-073043","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2024-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Vaso adjourns special meeting on business combination to September 10, 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Special meeting originally Aug 26, 2024 adjourned; will reconvene at Lever House, New York at 10:00 a.m. ET.","Stockholders to vote on proposals including approval of Business Combination with Achari Ventures Holdings Corp. I.","Record date for meeting remains close of business on July 15, 2024.","Definitive proxy statement filed with SEC on Aug 7, 2024 provides details on proposals and participant interests."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216721,"accession_number":"0001213900-24-072203","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2024-08-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Vaso provides pro forma combined financials for Achari merger; 2023 revenue $81.0M, net loss $0.7M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Six months ended June 30, 2024 pro forma combined revenue $39.0M, net loss $1.5M.","Year ended December 31, 2023 pro forma combined revenue $81.0M, net loss $0.7M.","Vaso stockholders expected to own 95.8% (current redemptions) or 97.4% (max redemptions) of combined company.","Pro forma balance sheet at June 30, 2024: total assets $69.4M (current redemptions) or $65.8M (max redemptions).","Merger must close by October 19, 2024; Achari trust account ~$6.3M after July 2024 redemptions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271525,"accession_number":"0001654954-23-015266","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2023-12-08T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Vaso Corporation to merge with SPAC Achari, uplist to Nasdaq at $176M valuation","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Vaso to combine with Achari Ventures (AVHI) at $176M equity value ($10/share); expected close Q1 2024.","Existing Vaso shareholders will receive shares of the surviving public company; no cash consideration.","Vaso common stock and warrants to list on Nasdaq as VASO and VASOW after closing.","Holders of 44% of Vaso shares signed support agreements to vote in favor of the deal.","Vaso CEO Jun Ma will continue as CEO of the combined company post-merger."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308893,"accession_number":"0001654954-23-004199","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2023-04-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Vaso Corporation appoints Leon Dembo as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leon Dembo appointed to Vaso's Board as independent director, effective April 3, 2023.","Mr. Dembo will serve in Class II until the 2025 Annual Meeting of Shareholders.","He has been managing partner of Dembo, Brown & Burns LLP since 1991 with 43 years of legal practice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361821,"accession_number":"0001654954-22-012632","cik":839087,"company_name":"VASO Corp","ticker":"VASO","form_type":"8-K","filed_at":"2022-09-16T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Vaso Corporation dismisses MaloneBailey, appoints UHY as new auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee approved UHY engagement on Aug 24, 2022; UHY accepted Sep 12, 2022.","Prior auditor MaloneBailey issued unmodified opinions for FY2020 and FY2021.","No disagreements or reportable events occurred during MaloneBailey's tenure.","Vaso did not consult UHY on any accounting or auditing matters before engagement.","Exhibit includes MaloneBailey letter confirming no disagreements with dismissal."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":39600000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}